| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRES
|
2.33 | 9.0B | 6.68 | 0.40 | 11.01 | — | — | 75 | 51 | 4.47 | +69.0% | 67 | 0.58 |
|
CBQK
|
4.22 | 17.1B | 7.62 | 0.63 | — | — | — | 70 | 48 | 5.93 | +25.9% | 89 | 1.53 |
|
QNBK
|
16.89 | 153.9B | 9.18 | 1.25 | — | — | — | 68 | 63 | 21.73 | +21.2% | 91 | 0.85 |
|
QIBK
|
21.57 | 51.0B | 10.75 | 1.52 | — | — | — | 67 | 58 | 24.74 | +10.1% | 91 | 0.69 |
|
DHBK
|
2.70 | 8.4B | 9.80 | 0.53 | — | — | — | 62 | 36 | 3.69 | +23.5% | 89 | 1.57 |
|
ABQK
|
3.88 | 9.9B | 11.27 | 1.14 | — | — | — | 60 | 46 | 3.90 | +0.3% | 90 | 0.59 |
|
MARK
|
1.96 | 18.2B | 13.25 | 0.71 | — | — | — | 58 | 24 | 1.98 | +0.5% | 89 | 0.49 |
|
QIIK
|
10.97 | 16.6B | 13.33 | 2.09 | — | — | — | 58 | 47 | 8.73 | -14.1% | 91 | 1.30 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.